Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01477723 · ClinicalTrials.gov registry record · Phase 3
Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients
A Phase 3 study, sponsored by Abbott Nutrition.
- Terminated
- Registry status
- Phase 3
- Development phase
- 17
- Enrollment target
NCT01477723: Clinical Trial Phase 3 study, sponsored by Abbott Nutrition.
NCT01477723 is a Phase 3 study that was terminated before completion, run by Abbott Nutrition. The registered enrollment target is 17 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01477723, a Phase 3 study, was terminated before completion, sponsored by Abbott Nutrition.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 17 participants
- Enrollment target
Study Summary
Study objectives are to verify the loss of lean mass during a hospital stay in a group of older patients; to evaluate the effects of consuming a high-calorie complete and balanced oral nutritional supplement; to collect post-discharge information.
Interventions
- OTHER Experimental Oral Nutritional Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-11 |
| Phase | Phase 3 |
Why NCT01477723 stopped before completion
NCT01477723 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Experimental Oral Nutritional Supplement is the first listed.
NCT01477723 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01477723 about?
NCT01477723 is a clinical study titled "Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients". Study objectives are to verify the loss of lean mass during a hospital stay in a group of older patients; to evaluate the effects of consuming a high-calorie complete and balanced oral nutritional supplement; to collect post-discharge information.
What is the current status of trial NCT01477723?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 17 participants. The study started on 2011-10. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01477723?
The interventions under investigation include: Experimental Oral Nutritional Supplement (OTHER).
Who is sponsoring clinical trial NCT01477723?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01477723's enrollment target sits among peer trials
17 1971st of 2000 higher than 27 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia